gptkbp:instanceOf
|
patent
|
gptkbp:communityFeedback
|
positive reviews
|
gptkbp:hasAbstract
|
This patent describes a method for treating a specific disease using a novel compound.
|
gptkbp:hasAffiliation
|
anti-inflammatory
|
gptkbp:hasAssignee
|
gptkb:Pharma_Corp.
|
gptkbp:hasCitations
|
5
|
gptkbp:hasClaim
|
20
|
gptkbp:hasClient
|
ingredient_Y
|
gptkbp:hasCollaborationsWith
|
University C
|
gptkbp:hasCompetitors
|
competitor E
|
gptkbp:hasContribution
|
pharmacies
1 million units
|
gptkbp:hasCountry
|
gptkb:USA
|
gptkbp:hasDeveloped
|
brand name A
post-market
|
gptkbp:hasExaminer
|
Jane_Smith
|
gptkbp:hasFacility
|
none
|
gptkbp:hasFeature
|
positive
|
gptkbp:hasFieldOfUse
|
medical
|
gptkbp:hasFilingDate
|
2004-02-06
|
gptkbp:hasFilm
|
nausea
|
gptkbp:hasFunding
|
grant B
|
gptkbp:hasInternationalClassification
|
A61K
|
gptkbp:hasInventor
|
gptkb:John_Doe
|
gptkbp:hasLegalStatus
|
active
|
gptkbp:hasLocalCuisine
|
NCT01234567
|
gptkbp:hasOccupation
|
yes
|
gptkbp:hasPartnershipsWith
|
ongoing
|
gptkbp:hasPatentNumber
|
6,789,347
|
gptkbp:hasPerformedAt
|
tablet
|
gptkbp:hasPersonnel
|
exclusive license
|
gptkbp:hasPopulation
|
adults
|
gptkbp:hasPriorityDate
|
2004-09-14
2003-02-06
2024-09-14
|
gptkbp:hasPrograms
|
well-tolerated
process Z
|
gptkbp:hasPublications
|
2004-0123456
|
gptkbp:hasRelatedPatent
|
utility patent
incremental innovation
US_6,789,346
|
gptkbp:hasResearchInterest
|
pharmaceutical chemistry
synthesis method
Journal_D
|
gptkbp:hasSubsidiary
|
compound X
|
gptkbp:hasTechnology
|
yes
|
gptkbp:hasTitle
|
Method for treating a disease
|
gptkbp:hasTransportation
|
extended release
|
https://www.w3.org/2000/01/rdf-schema#label
|
US 6,789,347 I26
|
gptkbp:isAttendedBy
|
gptkb:FDA
|
gptkbp:isFiledIn
|
gptkb:United_States
|
gptkbp:isPartOf
|
patent family
|
gptkbp:isRelatedTo
|
disease treatment
|
gptkbp:market
|
available
|
gptkbp:route
|
oral
|